MedTrace Logo

Sleep Architecture and Chemotherapy-Related Fatigue

NCT00178204 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2014-12-05

No results posted yet for this study

Summary

The purpose of this study is to identify specific chemotherapy-related changes in sleep stages/architecture that may relate to an increase in fatigue in individuals with cancer.

The researchers hypothesize that the fatigue experienced by cancer patients receiving chemotherapy is in part due to changes in restorative sleeping during the non-rapid eye movement cycles of sleep (i.e., delta activity).

Conditions

Sponsors & Collaborators

  • American Cancer Society, Inc.

    collaborator OTHER

  • University of Rochester

    lead OTHER

Principal Investigators

  • Joesph A Roscoe, Ph.D. · University of Rochester

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Primary Completion
2009-05-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00178204 on ClinicalTrials.gov